Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention ...
Wer hätte gedacht, dass ein kleines Biotech-Unternehmen aus Mainz den Kampf gegen Darmkrebs neu definieren könnte? Mainz ...
The new partnership combines Mainz Biomed's expertise in DNA-based diagnostics with labor team w's strong track record in ...
Mainz Biomed partners with labor team to launch DNA-based ColoAlert® colorectal cancer screening in Switzerland, enhancing early detection efforts. Mainz Biomed N.V. has announced a strategic ...
Darmkrebsmonat März: Mainz Biomed setzt sich für einen Wechsel von Diagnose zur Prävention ein ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
11d
Mainz Biomed expandiert durch die Partnerschaft mit labor team w in die Schweiz Partnerschaft zur Markteinführung des ...
7h
Lowering barriers to CRC screening is crucial in empowering both patients and healthcare professionals in early cancer detection. One key initiative is increasing accessibility through at-home testing ...
BERKELEY, Calif. and MAINZ, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics ...
BERKELEY, US – MAINZ, Germany – February 20, 2025 -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the“Company”), a molecular genetics diagnostic company specializing in the early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback